Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience v drug-eluting stent in the treatment of de novo coronary stenosis: A randomized trial

American Heart Journal

Volumn 166, Issue 5, 2013, Pages 920-926

  Liistro, Francesco ^a   Porto, Italo ^a   Angioli, Paolo ^a   Grotti, Simone ^a,b   Ducci, Kenneth ^a   Falsini, Giovanni ^a   Bolognese, Leonardo ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ELUTAX; EVEROLIMUS; PACLITAXEL; UNCLASSIFIED DRUG;

AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR EQUIPMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PACLITAXEL ELUTING BALLOON; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STABLE ANGINA PECTORIS;

AGED; AGED, 80 AND OVER; ANGINA, STABLE; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; STENTS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84886847818     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.08.023     Document Type: Article

References (30)

1. S. Bangalore, S. Kumar, and M. Fusaro Short and long-term outcomes with drug eluting and bare metal coronary stents: a mixed treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
2. F. Airoldi, A. Colombo, and N. Morici Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment Circulation 116 2007 745 754
3. U. Speck, B. Cremers, and B. Kelsch Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel? Circ Cardiovasc Interv 5 2012 392 400
4. B. Scheller, U. Speck, and C. Abramjuk Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis Circulation 110 2004 810 814
5. H. Rittger, J. Brachmann, and A.M. Sinha A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 2012 1377 1382
6. R.M. Ali, R. Degenhardt, and R. Zambahari Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus EuroIntervention Suppl K 2011 K83 K92
7. A. Micari, A. Cioppa, and G. Vadalà A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: acute and midterm results EuroIntervention Suppl K 2011 K77 K82
8. F. Liistro, I. Porto, and S. Grotti Drug-eluting balloon angioplasty for carotid in-stent restenosis J Endovasc Ther 19 2012 729 733
9. A.J. Black, D.L. Namay, and A.L. Niederman Tear or dissection after coronary angioplasty. Morphologic correlates of an ischemic complication Circulation 79 1989 1035 1042
10. G.S. Mintz, J.J. Popma, and A.D. Pichard Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study Circulation 94 1996 35 43
11. A.B.J. Ruebben, and N. Weiss Drug-eluting balloon analysis Interv Cardiol (Touch briefings) 4 2010 74 76
12. P. Garrone, G. Biondi-Zoccai, and I. Salvetti Quantitative coronary angiography in the current era: principles and applications J Interv Cardiol 22 2009 527 536
13. G. Guagliumi, M.A. Costa, and V. Sirbu Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial Circulation 123 2011 274 281
14. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
15. R. Mehran, G. Dangas, and A.S. Abizaid Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878
16. G.W. Stone, M. Midei, and W. Newman Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA 299 2008 1903 1913
17. H. Roukoz, A.A. Bavry, and M.L. Sarkees Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up Am J Med 122 2009 581.e1 581.e10
18. A. Kastrati, J. Mehilli, and J. Pache Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039
19. J. Pöss, C. Jacobshagen, and C. Ukena Hotlines and clinical trial updates presented at the German Cardiac Society Meeting 2010: FAIR-HF, CIPAMI, LIPSIA-NSTEMI, Handheld-BNP, PEPCAD III, remote ischaemic conditioning, CERTIFY, PreSCD-II, German Myocardial Infarction Registry, DiaRegis Clin Res Cardiol 99 2010 411 417
20. D. Fischer, B. Scheller, and A. Schafer Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study EuroIntervention 8 2012 450 455
21. F.T. Bourgeois, S. Murthy, and K.D. Mandl Outcome reporting among drug trials registered in ClinicalTrials.gov Ann Intern Med 153 2010 158 166
22. J.L. Gutiérrez-Chico, R.J. van Geuns, and K.T. Koch Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first EuroIntervention 7 2011 711 722
23. T.C. Poerner, S. Otto, and F. Janiak A prospective randomized study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6 months after implantation of a coronary everolimus-eluting stent compared with bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS trial) J Am Coll Cardiol 59 2012 E281
24. J. Mieres, C. Fernandez-Pereira, and G. Risau One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR) Cardiovasc Revasc Med 13 2012 265 271
25. A. Belkacemi, P. Agostoni, and H.M. Nathoe First results of the DEB-AMI (Drug Eluting Balloon in Acute ST-Segment Elevation Myocardial Infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes J Am Coll Cardiol 59 2012 2327 2337
26. G.M. Frohlich, A.J. Lansky, and D.T. Ko Drug eluting balloons for de novo coronary lesions - a systematic review and meta-analysis BMC Med 11 2013 123
27. T. Zhang, S. Sun, and L. Shen Drug-eluting balloons for de novo coronary artery disease: a meta-analysis of angiographic and clinical data Catheter Cardiovasc Interv 22 2013 1 10
28. U. Speck, B. Scheller, and W. Rutsch Local drug delivery - the early Berlin experience: single drug administration versus sustained release EuroIntervention Suppl K 2011 K17 22
29. A.J. Lansky, R.A. Costa, and G.S. Mintz Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial Circulation 109 2004 1948 1954
30. P.W. Radke, M. Joner, and A. Joost Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients EuroIntervention 7 2011 730 737